COVID-19

“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”

CEO Robert Ford says “dynamics” of more consumers fortifying their diets to promote immunity from COVID-19 “are driving strong growth for our Ensure and Glucerna brands.” Analysts don't share Ford's confidence, though, for continued OTC diagnostics sales growth. 

HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

Trial with 214 adults with SARS-CoV-2 showed no significant difference among the treatment groups in number of days to symptom relief. Study didn’t measure zinc/vitamin C supplementation for shortening duration of colds.

To mark International Self-Care Day, HBW Insight talks to the Global Self Care Federation's director general, Judy Stenmark, about the impact of pandemic on the global self-care industry, as well as what GSCF is doing to promote self-care in the wake of the pandemic.

In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.

McGill University researchers say multiple analyses of genetic variants study showed no association between genetically predicted vitamin D level and COVID-19 susceptibility, hospitalization or severe disease. CRN’s Vitamin D & Me! campaign reaches 5.6m consumers.

The final day of PAGB's Digital Week focused on digital self-care and featured sessions on understanding human behavior, the problem of online health misinformation and how best to navigate the new post-COVID reality.